Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
Open Access
Abstract
Regulatory T cells (Tregs) are present in a large majority of solid tumors and are mainly associated with a poor prognosis, as their major function is to inhibit the antitumor immune response contributing to immunosuppression. In this review, we will investigate the mechanisms involved in the recruitment, amplification and stability of Tregs in the tumor microenvironment (TME). We will also review the strategies currently developed to inhibit Tregs’ deleterious impact in the TME by either inhibiting their recruitment, blocking their expansion, favoring their plastic transformation into other CD4+ T-cell subsets, blocking their suppressive function or depleting them specifically in the TME to avoid severe deleterious effects associated with Treg neutralization/depletion in the periphery and normal tissues.Keywords
Funding Information
- LYRICAN INCa DGOS (INCa-DGOS-Inserm 12563)
- LABEX DEVWECAN (ANR-10-LABX-0061)
- IDEX Investissements d’Avenir (ANR-11-IDEX-0007)
- Ligue Contre le Cancer (PhD fellowship)
This publication has 394 references indexed in Scilit:
- Biological Characteristics and Genetic Heterogeneity between Carcinoma-Associated Fibroblasts and Their Paired Normal Fibroblasts in Human Breast CancerPLOS ONE, 2013
- Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile InflammationImmunity, 2013
- Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinomaInternational Journal of Cancer, 2012
- Subsets of human CD4+ regulatory T cells express the peripheral homing receptor CXCR3European Journal of Immunology, 2011
- CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3Cancer Cell, 2011
- An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell ResponsivenessImmunity, 2010
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and ImmunityImmunity, 2010
- OX40 costimulation can abrogate Foxp3+ regulatory T cell‐mediated suppression of antitumor immunityInternational Journal of Cancer, 2009
- Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and PeripheryImmunity, 2008
- VEGF165 mediates formation of complexes containing VEGFR‐2 and neuropilin‐1 that enhance VEGF165‐receptor bindingJournal of Cellular Biochemistry, 2002